Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

M Alves de Inda; D van Strijp; E den Biezen-Timmermans; A van Brussel; J Wrobel; H van Zon; P Vos; GS Baillie; P Tennstedt; T Schlomm; MD Houslay; C.H. Bangma; R Hoffmann

doi:10.1016/j.euf.2017.05.010

Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

M Alves de Inda
, D van Strijp
, E den Biezen-Timmermans
, A van Brussel
, J Wrobel
, H van Zon
, P Vos
, GS Baillie
, P Tennstedt
, T Schlomm
, MD Houslay
, C.H. Bangma
, R Hoffmann

Urology

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

30 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	376-384
Number of pages	9
Journal	European Urology Focus
Volume	4
Issue number	3
DOIs	https://doi.org/10.1016/j.euf.2017.05.010
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-49-01

Access to Document

10.1016/j.euf.2017.05.010

REPUB_100550-OA.pdfFinal published version, 1.51 MB

Cite this

Alves de Inda, M., van Strijp, D., den Biezen-Timmermans, E., van Brussel, A., Wrobel, J., van Zon, H., Vos, P., Baillie, GS., Tennstedt, P., Schlomm, T., Houslay, MD., Bangma, C. H., & Hoffmann, R. (2018). Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes. European Urology Focus, 4(3), 376-384. https://doi.org/10.1016/j.euf.2017.05.010

@article{13cac43d02724c6387d5914e18ad7c5f,

title = "Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes",

author = "\{Alves de Inda\}, M and \{van Strijp\}, D and \{den Biezen-Timmermans\}, E and \{van Brussel\}, A and J Wrobel and \{van Zon\}, H and P Vos and GS Baillie and P Tennstedt and T Schlomm and MD Houslay and C.H. Bangma and R Hoffmann",

year = "2018",

doi = "10.1016/j.euf.2017.05.010",

language = "Undefined/Unknown",

volume = "4",

pages = "376--384",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier",

number = "3",

}

Alves de Inda, M, van Strijp, D, den Biezen-Timmermans, E, van Brussel, A, Wrobel, J, van Zon, H, Vos, P, Baillie, GS, Tennstedt, P, Schlomm, T, Houslay, MD, Bangma, CH & Hoffmann, R 2018, 'Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes', European Urology Focus, vol. 4, no. 3, pp. 376-384. https://doi.org/10.1016/j.euf.2017.05.010

Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes. / Alves de Inda, M; van Strijp, D; den Biezen-Timmermans, E et al.
In: European Urology Focus, Vol. 4, No. 3, 2018, p. 376-384.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

AU - Alves de Inda, M

AU - van Strijp, D

AU - den Biezen-Timmermans, E

AU - van Brussel, A

AU - Wrobel, J

AU - van Zon, H

AU - Vos, P

AU - Baillie, GS

AU - Tennstedt, P

AU - Schlomm, T

AU - Houslay, MD

AU - Bangma, C.H.

AU - Hoffmann, R

PY - 2018

Y1 - 2018

U2 - 10.1016/j.euf.2017.05.010

DO - 10.1016/j.euf.2017.05.010

M3 - Article

C2 - 28753810

SN - 2405-4569

VL - 4

SP - 376

EP - 384

JO - European Urology Focus

JF - European Urology Focus

IS - 3

ER -